$NVCT
Nuvectis Pharma, Inc. Common Stock
XNAS
Why is NVCT down today? It is at $19.02 (-1.25%), and our scanner flagged it 17 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment NVCT spikes, and full due diligence on NVCT — key stats, earnings, dilution and insider activity. Free.
Get free $NVCT alerts the moment volume spikes
Our scanner flagged $NVCT 17 times in the last 30 days. Create a free account to track $NVCT, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $19.02
- Change today
- -1.25%
- Previous close
- $19.26
- 52-week range
- $5.55 – $29.27
- Market cap
- $511M
- Institutional own.
- 16.91%
- Total held
- 42.0%
- Tradeable float
- 18.9M 58% of shares · after 25% insiders + 17% institutions
- Short interest
- 1.5M ▼ -16% vs prior · as of 2026-07-15
- Short % of float
- 8.0%
- Days to cover
- 4.0d
- Avg daily volume
- 136K
- Exchange
- XNAS
- 5m
- 1.6x
- 15m
- 1.0x
- 1h
- 0.8x
- 1D
- 0.3x
Get free NVCT + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $NVCT down today?
NVCT is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on NVCT today, peaking at 27.4x its normal volume.
Likely catalystQuarterly report (10-Q), from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
Insiders buying4 open-market buys6 buys, 0 sells last 3 months (17/0 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Bentsur Ron Officer | Bought (open market) | +13K 0.05% of company | added 0.3% | 3.69M | $250K at $20.00 | Jun 30, 26 |
Mosseri Marlio Charles Beneficial Owner (10%) | Bought (open market) | +50K 0.2% of company | added 1.6% | 3.19M | $916K at $18.32 | Jun 30, 26 |
Kaplan Matthew L. Director | Acquired (grant/award) | +35K 0.1% of company | added 28% | 160K | n/a | Jun 11, 26 |
Sanchez Juan Director | Acquired (grant/award) | +35K 0.1% of company | added 45% | 113K | n/a | Jun 11, 26 |
Oliviero James F Iii Director | Acquired (grant/award) | +35K 0.1% of company | added 40% | 123K | n/a | Jun 11, 26 |
Hoberman Kenneth Director | Acquired (grant/award) | +35K 0.1% of company | added 26% | 168K | n/a | Jun 11, 26 |
Carson Michael J. Officer | Acquired (grant/award) | +61K 0.2% of company | added 44% | 200K | n/a | Jan 6, 26 |
Poradosu Enrique Officer | Acquired (grant/award) | +150K 0.6% of company | added 9.1% | 1.81M | n/a | Jan 6, 26 |
Bentsur Ron Officer | Acquired (grant/award) | +150K 0.6% of company | added 4.3% | 3.68M | n/a | Jan 6, 26 |
Shemesh Shay Officer | Acquired (grant/award) | +150K 0.6% of company | added 9.1% | 1.79M | n/a | Jan 6, 26 |
Kaplan Matthew L. Director | Bought (open market) | +11K 0.04% of company | added 9.7% | 125K | $64K at $5.84 | Nov 5, 25 |
Sanchez Juan Director | Bought (open market) | +13K 0.05% of company | added 20% | 78K | $75K at $5.79 | Nov 5, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Active shelfRecent share offering + active shelf on file — the company raised capital and can raise more. If $NVCT runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- Priced at $20.00/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$NVCT Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$NVCT Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
NVCT stock FAQ
Why is $NVCT down today?
NVCT is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on NVCT today, peaking at 27.4x its normal volume.
What is the NVCT stock price today?
NVCT last traded at $19.02, down 1.25% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live NVCT alerts?
The NVCT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged NVCT 17 times in the last 30 days.
What exchange is NVCT on?
NVCT (Nuvectis Pharma, Inc. Common Stock) trades on XNAS, with a market cap of about $511M.
Is NVCT good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge NVCT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.